S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stenocare A/S
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Net Change in Cash
kr5.1m
CAGR 3-Years
3%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Net Change in Cash
kr27.1B
CAGR 3-Years
89%
CAGR 5-Years
59%
CAGR 10-Years
24%
H Lundbeck A/S
CSE:HLUN A
Net Change in Cash
kr1.5B
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Net Change in Cash
kr253m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Net Change in Cash?
Net Change in Cash
5.1m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Net Change in Cash amounts to 5.1m DKK.

What is Stenocare A/S's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-23%

The average annual Net Change in Cash growth rates for Stenocare A/S have been 3% over the past three years , -23% over the past five years .

Back to Top